Motif BioSciences, Inc. Reports Half-Year 2017 Financial Results And Operational Progress Post author:Sam Post published:September 28, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Takeda's $5 Billion Bet on Ariad Pays Off With Accelerated Approval of Lung Cancer Med April 30, 2017 Novogen Terminates Preclinical Program, Will Cut an Undisclosed Number of Jobs April 5, 2017 On a Roll: Magenta Therapeutics Nabs Another $50 Million, a Drug From Novartis AG and Deal With May 1, 2017
Takeda's $5 Billion Bet on Ariad Pays Off With Accelerated Approval of Lung Cancer Med April 30, 2017
On a Roll: Magenta Therapeutics Nabs Another $50 Million, a Drug From Novartis AG and Deal With May 1, 2017